SOD2-deficiency anemia: Protein oxidation and altered protein expression reveal targets of damage, stress response, and antioxidant responsiveness

Blood

Volumn 104, Issue 8, 2004, Pages 2565-2573

  Friedman, Jeffrey S ^a   Lopez, Mary F ^b   Fleming, Mark D ^b   Rivera, Alicia ^b   Martin, Florent M ^b   Welsh, Megan L ^b   Boyd, Ashleigh ^b   Doctrow, Susan R ^b   Burakoff, Steven J ^b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIOXIDANT; CELL PROTEIN; HYDROGEN PEROXIDE; PROTEOME; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; SUPEROXIDE DISMUTASE;

ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BONE MARROW; CONTROLLED STUDY; ENZYME DEFICIENCY; ERYTHROCYTE LIFESPAN; FLUORESCENCE ACTIVATED CELL SORTING; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RETICULOCYTE; SPLEEN;

EID: 4944225788     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-11-3858     Document Type: Article

References (49)

1. Friedman JS, Rebel VI, Derby R, et al. Absence of mitochondrial Superoxide dismutase results in a murine hemolytic anemia responsive to therapy with a catalytic antioxidant. J Exp Med. 2001;193: 925-934.
2. Fleming MD. The genetics of inherited sideroblastic anemias. Semin Hematol. 2002;39:270-281.
3. Cotter PD, Rucknagel DL, Bishop DF. X-linked sideroblastic anemia: identification of the mutation in the erythroid-specific delta-aminolevulinate synthase gene (ALAS2) in the original family described by Cooley. Blood. 1994;84:3915-3924.
4. Allikmets R, Raskind WH, Hutchinson A, Schueck ND, Dean M, Koeller DM. Mutation of a putative mitochondrial iron transporter gene (ABC7) in X-linked sideroblastic anemia and ataxia (XLSA/ A). Hum Mol Genet. 1999;8:743-749.
5. Fleming MD, Campagna DR, Haslett JN, Trenor CC 3rd, Andrews NC. A mutation in a mitochondrial transmembrane protein is responsible for the pleiotropic hematological and skeletal phenotype of flexed-tail (f/f) mice. Genes Dev. 2001;15:652-657.
6. Pearson HA, Lobel JS, Kocoshis SA, et al. A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction. J Pediatr. 1979;95:976-984.
7. Gattermann N, Retzlaff S, Wang YL, et al. Heteroplasmic point mutations of mitochondrial DNA affecting subunit I of cytochrome c oxidase in two patients with acquired idiopathic sideroblastic anemia. Blood. 1997;90:4961-4972.
8. Gattermann N, Retzlaff S, Wang YL, et al. A heteroplasmic point mutation of mitochondrial tRNALeu(CUN) in non-lymphoid haemopoietic cell lineages from a patient with acquired idiopathic sideroblastic anaemia. Br J Haematol. 1996;93:845-855.
9. Wang YL, Choi HK, Aul C, Gattermann N, Heinisch J. The MERRF mutation of mitochondrial DNA in the bone marrow of a patient with acquired idiopathic sideroblastic anemia. Am J Hematol. 1999;60:83-84.
10. Beck EA, Ziegler G, Schmid R, Ludin H. Reversible sideroblastic anemia caused by chloramphenicol. Acta Haematol. 1967;38:1-10.
11. Yunis AA, Salem Z. Drug-induced mitochondrial damage and sideroblastic change. Clin Haematol. 1980;9:607-619.
12. Sharp RA, Lowe JG, Johnston RN. Anti-tuberculous drugs and sideroblastic anaemia. Br J Clin Pract. 1990;44:706-707.
13. Keyhani M, Giuliani D, Giuliani ER, Morse BS. Erythropoiesis in pyridoxine deficient mice. Proc Soc Exp Biol Med. 1974;146:114-119.
14. Lebovitz RM, Zhang H, Vogel H, et al. Neurodegeneration, myocardial injury, and perinatal death in mitochondrial Superoxide dismutase-deficient mice. Proc Natl Acad Sci U S A. 1996;93:9782-9787.
15. Li Y, Huang TT, Carlson EJ, et al. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese Superoxide dismutase. Nat Genet. 1995;11:376-381.
16. Melov S, Coskun P, Patel M, et al. Mitochondrial disease in Superoxide dismutase 2 mutant mice. Proc Natl Acad Sci U S A. 1999;96:846-851.
17. Melov S, Ravenscroft J, Malik S, et al. Extension of life-span with Superoxide dismutase/catalase mimetics. Science. 2000;289:1567-1569.
18. Melov S, Doctrow SR, Schneider JA, et al. Lifespan extension and rescue of spongiform encephalopathy in Superoxide dismutase 2 nullizygous mice treated with Superoxide dismutase-catalase mimetics. J Neurosci. 2001;21:8348-8353.
19. Hoffmann-Fezer G, Maschke H, Zeitler HJ, et al. Direct in vivo biotinylation of erythrocytes as an assay for red cell survival studies. Ann Hematol. 1991;63:214-217.
20. Lopez MF, Melov S. Applied proteomics: mitochondrial proteins and effect on function. Circ Res. 2002;90:380-389.
21. Pluskal MG, Bogdanova A, Lopez M, Gutierrez S, Pitt AM. Multiwell in-gel protein digestion and microscale sample preparation for protein identification by mass spectrometry. Proteomics. 2002;2: 145-150.
22. Lopez MF, Patton WF. Reproducibility of polypeptide spot positions in two-dimensional gels run using carrier ampholytes in the isoelectric focusing dimension. Electrophoresis. 1997;18:338-343.
23. Melov S. Mitochondrial oxidative stress. Physiologic consequences and potential for a role in aging. Ann N Y Acad Sci. 2000;908:219-225.
24. Levine RL, Williams JA, Stadtman ER, Shacter E. Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol. 1994;233: 346-357.
25. Stadtman ER. Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions. Annu Rev Biochem. 1993;62:797-821.
26. Devadas S, Zaritskaya L, Rhee SG, Oberley L, Williams MS. Discrete generation of Superoxide and hydrogen peroxide by T cell receptor stimulation: selective regulation of mitogen-activated protein kinase activation and fas ligand expression. J Exp Med. 2002;195:59-70.
27. Edwards JA, Hoke JE. Red cell iron uptake in hereditary microcytic anemia. Blood. 1975;46:381-388.
28. Tampo Y, Kotamraju S, Chitambar CR, et al. Oxidative stress-induced iron signaling is responsible for peroxide-dependent oxidation of dichlorodihydrofluorescein in endothelial cells: role of transferrin receptor-dependent iron uptake in apoptosis. Circ Res. 2003;92:56-63.
29. De Franceschi L, Fattovich G, Turrini F, et al. Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: role of membrane oxidative damage. Hepatology. 2000;31:997-1004.
30. Haas M, Harrison JH Jr. Stimulation of K-C1 cotransport in rat red cells by a hemolytic anemia-producing metabolite of dapsone. Am J Physiol. 1989;256:C265-C272.
31. Olivieri O, Bonollo M, Friso S, Girelli D, Corrocher R, Vettore L. Activation of K+/Cl- cotransport in human erythrocytes exposed to oxidative agents. Biochim Biophys Acta. 1993;1176:37-42.
32. Scott MD, van den Berg JJ, Repka T, et al. Effect of excess alpha-hemoglobin chains on cellular and membrane oxidation in model beta-thalassemic erythrocytes. J Clin Invest. 1993;91:1706-1712.
33. Pootrakul P, Wattanasaree J, Anuwatanakulchai M, Wasi P. Increased red blood cell protoporphyrin in thalassemia: a result of relative iron deficiency. Am J Clin Pathol. 1984;82:289-293.
34. Nijtmans LG, de Jong L, Artal Sanz M, et al. Prohibitins act as a membrane-bound chaperone for the stabilization of mitochondrial proteins. EMBO J. 2000;19:2444-2451.
35. Cabiscol E, Belli G, Tamarit J, Echave P, Herrero E, Ros J. Mitochondrial Hsp60, resistance to oxidative stress, and the labile iron pool are closely connected in Saccharomyces cerevisiae. J Biol Chem. 2002;277:44531-44538.
36. Armsby CC, Brugnara C, Alper SL. Cation transport in mouse erythrocytes: role of K(+)-Cl-cotransport in regulatory volume decrease. Am J Physiol. 1995;268:C894-C902.
37. Tamarit J, Cabiscol E, Ros J. Identification of the major oxidatively damaged proteins in Escherichia coli cells exposed to oxidative stress. J Biol Chem. 1998;273:3027-3032.
38. Hultquist DE, Passon PG. Catalysis of methaemoglobin reduction by erythrocyte cytochrome B5 and cytochrome B5 reductase. Nat New Biol. 1971;229:252-254.
39. Chikuba K, Yubisui T, Shirabe K, Takeshita M. Cloning and nucleotide sequence of a cDNA of the human erythrocyte NADPH-flavin reductase. Biochem Biophys Res Commun. 1994;198:1170-1176.
40. Kang SW, Chae HZ, Seo MS, Kim K, Baines IC, Rhee SG. Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-alpha. J Biol Chem. 1998;273:6297-6302.
41. Drake SK, Bourdon E, Wehr N, et al. Numerous proteins in mammalian cells are prone to iron-dependent oxidation and proteasomal degradation. Dev Neurosci. 2002;24:114-124.
42. Rabilloud T, Heller M, Gasnier F, et al. Proteomics analysis of cellular response to oxidative stress: evidence for in vivo overoxidation of peroxiredoxins at their active site. J Biol Chem. 2002;277: 19396-19401.
43. Lee TH, Kim SU, Yu SL, et al. Peroxiredoxin II is essential for sustaining life span of erythrocytes in mice. Blood. 2003;101:5033-5038.
44. Brown JP, Woodbury RG, Hart CE, Hellstrom I, Hellstrom KE. Quantitative analysis of melanoma-associated antigen p97 in normal and neoplastic tissues. Proc Natl Acad Sci U S A. 1981; 78:539-543.
45. Kennard ML, Richardson DR, Gabathuler R, Ponka P, Jefferies WA. A novel iron uptake mechanism mediated by GPI-anchored human p97. EMBO J. 1995;14:4178-4186.
46. Richardson DR. The role of the membrane-bound tumour antigen, melanotransferrin (p97), in iron uptake by the human malignant melanoma cell. Eur J Biochem. 2000;267:1290-1298.
47. Hillery CA, Du MC, Montgomery RR, Scott JP. Increased adhesion of erythrocytes to components of the extracellular matrix: isolation and characterization of a red blood cell lipid that binds thrombospondin and laminin. Blood. 1996;87: 4879-4886.
48. Manodori AB, Barabino GA, Lubin BH, Kuypers FA. Adherence of phosphatidylserine-exposing erythrocytes to endothelial matrix thrombospondin. Blood. 2000;95:1293-1300.
49. Cabiscol E, Belli G, Tamarit J, Echave P, Herrero E, Ros J. Mitochondrial Hsp60, resistance to oxidative stress, and the labile iron pool are closely connected in Saccharomyces cerevisiae. J Biol Chem. 2002;277:44531-44538.